We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$918M
AUM Growth
+$78.7M
Cap. Flow
-$9.19M
Cap. Flow %
-1%
Top 10 Hldgs %
12.06%
Holding
631
New
69
Increased
135
Reduced
112
Closed
73

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$2.62M
2
SYM icon
Symbotic
SYM
+$2.58M
3
CLMB icon
Climb Global Solutions
CLMB
+$2.58M
4
ADBE icon
Adobe
ADBE
+$1.81M
5
ROAD icon
Construction Partners
ROAD
+$1.77M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.62M
2
VRNA
Verona Pharma
VRNA
+$3.24M
3
SHO icon
Sunstone Hotel Investors
SHO
+$2.69M
4
BAC icon
Bank of America
BAC
+$2.21M
5
AMGN icon
Amgen
AMGN
+$2.19M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Industrials 21.67%
3 Healthcare 15.84%
4 Consumer Discretionary 10.72%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKRO
476
DELISTED
Akero Therapeutics
AKRO
$377K 0.04%
7,941
+2,619
+49% +$127K
ESTA icon
477
Establishment Labs
ESTA
$2.24B
$369K 0.04%
8,994
KVYO icon
478
Klaviyo
KVYO
$5.09B
$362K 0.04%
13,084
-25,065
-66% -$809K
ASND icon
479
Ascendis Pharma A/S
ASND
$16.8B
$347K 0.04%
1,747
YOU icon
480
Clear Secure
YOU
$5.27B
$344K 0.04%
10,291
DOCS icon
481
Doximity
DOCS
$4.57B
$342K 0.04%
4,675
RES icon
482
RPC Inc
RES
$1.36B
$340K 0.04%
71,490
XPO icon
483
XPO
XPO
$23.5B
$340K 0.04%
2,629
WEX icon
484
WEX
WEX
$6.35B
$326K 0.04%
2,072
ESTC icon
485
Elastic
ESTC
$7.93B
$320K 0.03%
3,792
-1,038
-21% -$87.4K
FOLD
486
DELISTED
Amicus Therapeutics
FOLD
$317K 0.03%
40,211
+10,934
+37% +$77.8K
OMCL icon
487
Omnicell
OMCL
$1.7B
$310K 0.03%
10,189
GTLS
488
DELISTED
Chart Industries
GTLS
$308K 0.03%
1,540
-3,010
-66% -$572K
CMCO icon
489
Columbus McKinnon
CMCO
$557M
$307K 0.03%
21,391
-46,177
-68% -$695K
CRGO icon
490
Freightos
CRGO
$66.7M
$295K 0.03%
+89,541
New +$268K
SLGN icon
491
Silgan Holdings
SLGN
$4.35B
$292K 0.03%
6,789
-8,210
-55% -$397K
SAFT icon
492
Safety Insurance
SAFT
$1.52B
$283K 0.03%
4,003
-4,282
-52% -$311K
TKO icon
493
TKO Group
TKO
$13.8B
$283K 0.03%
1,399
-1,378
-50% -$252K
ORIC icon
494
Oric Pharmaceuticals
ORIC
$1.41B
$281K 0.03%
+23,396
New +$246K
MGY icon
495
Magnolia Oil & Gas
MGY
$6.16B
$274K 0.03%
11,497
PBH icon
496
Prestige Consumer Healthcare
PBH
$2.51B
$274K 0.03%
4,392
LEG icon
497
Leggett & Platt
LEG
$1.29B
$265K 0.03%
29,851
-35,783
-55% -$341K
SRAD icon
498
Sportradar
SRAD
$3.95B
$256K 0.03%
+9,509
New +$282K
EEFT icon
499
Euronet Worldwide
EEFT
$2.65B
$250K 0.03%
2,845
-546
-16% -$52.3K
METC icon
500
Ramaco Resources Class A
METC
$645M
$248K 0.03%
+7,459
New +$173K

Similar funds

Legato Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Legato Capital Management held 631 positions worth $918M, up 9.4% from $839M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Legato Capital Management's Q3 2025 filing shows 69 new, 135 increased, 112 reduced and 73 closed positions. Its largest new stake was Visteon: 22,225 shares worth $2.66M. The largest sale was Broadcom, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Legato Capital Management's largest Q3 2025 buy was Visteon: 22,225 shares worth $2.66M.
  • Legato Capital Management added most to Construction Partners in Q3 2025, an estimated $1.77M increase.
  • Legato Capital Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.62M.
  • Legato Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $3.24M.
  • Legato Capital Management's ten largest holdings make up 12% of its $918M portfolio in Q3 2025.
  • Legato Capital Management opened 69 new positions and closed 73 in Q3 2025.
  • Legato Capital Management's portfolio value rose 9.4% quarter-over-quarter to $918M.

Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.